Table 4.
Studies on ablation therapy for liver metastasis from gastric cancer
| Author | Publication year | Type of ablation | No. of patients | No. of tumors | Size of tumors [mm] | Follow-up [months] | Local tumor control [%] | Overall survival [months] | Overall survival [%] | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1-year | 2-year | 3-year | 4-year | 5-year | |||||||||
| Fan et al. [33] | 2020 | RFA | 46 | – | – | 24.9 (median) | – | 26.1 (median) | 58.7 | 23.9 | – | – | – |
| Zhou et al. [34] | 2017 | MWA | 32 | – | 38 (mean) | 19 (median) | 100 | 25 (median) | 80.9 | – | 31.2 | – | 16.7 |
| Hwang et al. [35] | 2014 | RFA | 44 | – | 20 (median) | 31.7 (median) | – | 14.7 (median) | – | – | – | – | – |
| Chen et al. [36] | 2013 | RFA | 21 | 32 | 38 (median) | 19 (median) | 81 | 14 (median) | 70 | 11 | 5 | – | 3 |
RFA radiofrequency ablation, MWA microwave ablation